Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

CEO moving on from Theolytics

Plus: CSO Luis Borges departs Metagenomi, and updates from Diadem and CureLab

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst 
July 13, 2024 12:42 AM UTC

Charlotte Casebourne Stock is moving on from her position as CEO of  Theolytics Ltd., the oncoloytic virus company she co-founded. Stock will become an adviser to Theolytics, which will be led by Executive Chair Mike Grey. 

CSO Luis Borges has left Metagenomi Inc. (NASDAQ:MGX), which went public on Feb. 8. Borges joined in August 2023 from Century Therapeutics Inc. (NASDAQ:IPSC). Shares in Metagenomi fell by $6.17 (60%) to $4.08 between the IPO and June 28. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Curelab Oncology Inc.

Metagenomi Inc.

Theolytics Ltd.